-
Has your treatment of menopausal women changed since the initial findings released from the Women's Health Initiative (WHI) randomized, controlled trials of hormone therapy (HT)? Findings from a just-published secondary analysis of data from the WHI indicate that women who initiated HT closer to menopause tended to have reduced risk of coronary heart disease (CHD), while women further from menopause tended to have a slightly higher risk for the disease.
-
Global policies are being updated with the recent issuance of recommendations from an expert consultation on male circumcision for HIV prevention.1 But what impact do the recommendations have on your practice?
-
In 1992, reproductive health advocates estimated that emergency contraceptive pills (ECPs) could prevent half of all unintended pregnancies and abortions in the United States each year.
-
Consider the following patients: a 15-year-old young mother, a 30-year-old married woman with no previous pregnancies, a 30-year-old single woman with no children, and a 30-year-old HIV-positive woman with three children. When discussing contraceptive options, do you include intrauterine contraception in talking with these women?
-
Update your practice when it comes to treatment of gonorrhea: The Centers for Disease Control and Prevention (CDC) no longer recommends the fluoroquinolone antibiotics ciprofloxacin, ofloxacin, and levofloxacin as a treatment for gonorrhea in the United States.
-
As clinicians begin to integrate use of the first cervical cancer vaccine (Gardasil, Merck & Co.; Whitehouse Station, NJ), the Food and Drug Administration (FDA) is set to review the application for a second vaccine.
-
Review the number of patients who were screened and treated for chlamydia at your facility in the last two weeks. What if their infection could have been prevented by vaccine?
-
If your practice includes women ages 50 and older, be sure to remind them to be screened for colorectal cancer, advises the American College of Obstetricians and Gynecologists (ACOG).
-
Good news on the research front: Results from a major study indicate that treating genital herpes may help keep the AIDS virus under control in women with both infections and may reduce the spread of HIV as well.
-
When you prescribe the contraceptive vaginal ring (NuvaRing, Organon; West Orange, NJ), you instruct the patient that the ring is worn for three weeks, then is removed for a one-week ring-free period. When the ring-free period is completed, a new ring must be used. But what if there was a ring that could be used for more than a three-week period?
